MANILA, Philippines — Local pharmaceutical company Unilab reminded the public Thursday to use paracetamol properly and within the recommended dose to ensure safety and efficacy.
Unilab issued the reminder amid the reported demand surge for paracetamol which is used to relieve pain and reduce fever.
“With the sudden surge of sickness today, people turn to paracetamol—a commonly used over-the-counter medication for fever, headache, and pain. But it’s important to remember its proper usage and dose to ensure safety and efficacy,” Unilab said in an advisory.
According to Unilab, the usual recommended dose for adults is one to two 500 milligram tablets every four to six hours.
The pharmaceutical firm said users should not exceed a maximum of eight tablets or 4,000 milligrams of paracetamol per day.
Unilab also advised the public not to use paracetamol with other products also containing paracetamols such as cough and cold preparations, fever ruducers, and pain relievers.
Other reminders include the following:
The Department of Trade and Industry and the Department of Health assured the public that there is no shortage of paracetamol and other drugs for flu-like symptoms amid the reported consumer rush.
In time for the celebration of World Diabetes Day on November 14, Unilab, Inc., the most trusted and leading pharmaceutical and healthcare company in the country, kicked off its nationwide Alagang Unilab Health and Wellness Fair in Pampanga.
Unilab, Inc., the Philippines’ largest pharmaceutical and healthcare company, marked World Quality Day on Nov. 14 by showcasing its Quality Alaga initiative, which emphasizes the importance of delivering high-quality healthcare products to Filipino families.
To address these gaps and support PhilHealth in expanding the implementation of Konsulta, the Unilab Center for Health Policy (UCHP) convened stakeholders from various sectors, including PhilHealth, local government units, private providers, and patient groups, in a roundtable discussion last September.
Unilab Inc.’s Solmux Advance with Zinc continues its commitment to community health through its “Huwag Palalain, Ubo ay Supilin” seminar for barangay health workers (BHWs) and extends its engagements in the Metro Manila cities of Malabon, Valenzuela, and Navotas.
Pharmaceutical giant Unilab disclosed that they have heavily invested in technology despite having only one distribution center (DC) nationwide.